Author

M. P. Philpott

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

A. Biddle· 2 shared C. L. Bishop· 2 shared G. Youssef· 2 shared I. C. Mackenzie· 2 shared L. Gammon· 2 shared R. Wallis· 2 shared A. Davis· 1 shared A. Gutierrez Del Arroyo· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Biddle

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Cell BiologybioRxivPreprintOct 23, 2023

SenPred: A single-cell RNA sequencing-based machine learning pipeline to classify senescent cells for the detection of an in vivo senescent cell burden

B. Hughes, A. Davis, D. Milligan…·C. L. Bishop

SenPred uses scRNA-seq to classify senescent cells and detects in vivo senescent cell burden with high accuracy.

DOI 10.1101/2023.10.23.563515

𝕏 PostBluesky

Cancer BiologybioRxivJun 7, 2023

A CD24+CD271+ Melanoma Cancer Stem Cell Possesses Hybrid Characteristics of its Single Marker Counterparts and Promotes Invasion and Therapeutic Resistance

O. Knowles, P. Doldan, I. Hillier-Richardson…·A. Biddle

The paper identifies a CD24+CD271+ melanoma sub-population with hybrid characteristics and enhanced invasive and therapeutic resistance properties.

DOI 10.1186/s12915-025-02336-2

humanexperimental assay

𝕏 PostBluesky

Cell BiologybioRxivSep 30, 2020

Early growth response 2 (EGR2) is a novel regulator of the senescence program

E. J. Tyler, A. Gutierrez Del Arroyo, R. Wallis…·C. L. Bishop

This study identifies EGR2 as a novel regulator of senescence by activating the ARF and p16 promoters and reversing the senescent phenotype upon its ablation.

DOI 10.1111/acel.13318

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivApr 7, 2020

Disseminating cells in human tumours acquire an EMT cancer stem cell state that is predictive of metastasis

G. Youssef, L. Gammon, L. Ambler…·A. Biddle

The paper identifies disseminating EMT cancer stem cells in human oral cancer specimens using EpCAM, CD24, and Vimentin markers, which predict metastasis with high accuracy.

DOI 10.7554/elife.90298

𝕏 PostBluesky